Center for Applied Proteomics and Molecular Medicine (CAPMM)

Mason will receive more than a $1 million for a center that will help in the fight against the growing opioid epidemic, and another $820,000 to establish a clinic that will help combat Lyme Disease and other tick-borne illnesses. Federal funding for both projects came as part of the federal omnibus appropriations bill that President Biden recently signed into law to fund the government through Fiscal Year 2023.

Outstanding Faculty Awards recognize faculty at Virginia’s public and private colleges and universities who exemplify the highest standards of teaching, scholarship and service. The award includes a $7,500 gift from the Dominion Energy Charitable Foundation when they are formally recognized at an in-person ceremony in Richmond on March 7.

A George Mason University team led by Alessandra Luchini and Lance Liotta has been named one of 10 Phase 1 winners of the LymeX Diagnostics Prize by the U.S. Department of Health and Human Services (HHS) and the Steven and Alexandra Cohen Foundation.

George Mason University researchers are playing a role in the Cancer Moonshot Initiative designed to reduce cancer deaths

Mason honors its COVID-19 surveillance testing team for its efforts during the pandemic.

A collaboration between the Honey Bee Initiative and Mason's new Forensic Science Research and Training Laboratory could yield critical advances in forensic science.

Two research professors at George Mason University, in collaboration with global partners, have discovered the same protein biomarkers in the saliva of youth and collegiate athletes who have experienced concussive and sub-concussive impacts.

Ceres Nanosciences, a Northern Virginia bioscience company spun out of George Mason University that specializes in diagnostic products and workflows, has opened a 12,000-square-foot advanced particle manufacturing plant in Prince William County’s Innovation Park.

During the coronavirus pandemic, Mason doctoral student Marissa Howard was able to get back into the Center for Applied Proteomics and Molecular Medicine (CAPMM) lab, but now all the researchers are working on COVID-19-related research.

COVID-19 antibody research by Mason scientists shows a lot of promise